OKUR · OnKure Therapeutics, Inc. · Analyst Estimates
$2.60
+0.12 (+4.85%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 4, 2026
The latest filing states the doubt was alleviated.
“As of December 31, 2025, the Company had determined that substantial doubt about the Company's ability to continue as a going concern for a period of at least 12 months from the date of the issuance of those financial statements did exist. However, following completion of the 2026 Private Placement (see Note 9), management believes the Company's cash, cash equivalents and marketable securities will be sufficient to fund its current operating plan for at least the next 12 months from the date of issuance of these condensed consolidated financial statements and as such substantial doubt has been alleviated.”View the 10-Q filed Aug 4, 2026
Market Cap
$105.09M
Shares
40.50M
Volume · Oct 27
320.24K
Avg daily vol (3M)
255.87K
Analyst Estimates
Compare analyst forecasts for OnKure Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 13:42 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-2.40
|
-1.83
|
-1.47
|
4
|
-1.96
|
-2.50
|
-2.50
|
-2.50
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0.00
|
250,000.00
|
1.00M
|
4
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-2.08
|
-1.53
|
-1.15
|
3
|
-1.96
|
-2.13
|
-2.13
|
-2.13
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0.00
|
666,670.00
|
2.00M
|
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.62
|
-0.41
|
-0.29
|
4
|
-0.47
|
-0.57
|
-0.57
|
-0.57
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0.00
|
125,000.00
|
500,000.00
|
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.67
|
-0.44
|
-0.30
|
4
|
-0.50
|
-0.60
|
-0.60
|
-0.60
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0.00
|
125,000.00
|
500,000.00
|
4
|
— | — | — | — | — | — | — | — |